BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology 22

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company formerly known as BeiGene, Ltd., today announced its new name and redomiciliation to Switzerland are officially in effect, marking a significant milestone in …